Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat.
about
Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytesGenomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of actionPredictive modeling of chemical hazard by integrating numerical descriptors of chemical structures and short-term toxicity assay dataTesting an aflatoxin B1 gene signature in rat archival tissues.Wind of change challenges toxicological regulators.Identification of consensus biomarkers for predicting non-genotoxic hepatocarcinogens.The toxicity and pathology of selected dietary herbal medicines.Xenobiotic CAR activators induce Dlk1-Dio3 locus non-coding RNA expression in mouse liver.Editor's Highlight: Application of Gene Set Enrichment Analysis for Identification of Chemically Induced, Biologically Relevant Transcriptomic Networks and Potential Utilization in Human Health Risk Assessment.Release of (and lessons learned from mining) a pioneering large toxicogenomics database.A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens.In vivo murine hepatic microRNA and mRNA expression signatures predicting the (non-)genotoxic carcinogenic potential of chemicals.An integrative test strategy for cancer hazard identification.Exploiting microRNA and mRNA profiles generated in vitro from carcinogen-exposed primary mouse hepatocytes for predicting in vivo genotoxicity and carcinogenicity.
P2860
Q28025433-B0767E48-9F60-4BFD-AF88-A0F392D38536Q28541142-931AC1EA-1FDF-4B40-8485-F781E8DB01BAQ28730554-DF4803D8-F2DA-4C29-BAC2-90A6F4CBAE75Q35981453-29FB9F5E-D2E2-473D-9067-21FFBCFEF7A9Q36566662-225055D1-7E20-4729-A7D8-564A3D6A5652Q37602048-91F27CC8-64F7-433F-A733-F2D62577A158Q38069420-81A7CBCF-6FC9-4C08-90E2-D67CA0901F5DQ38765423-D64D86B8-1040-4C29-9D8B-BE63DAD9DE78Q38998867-E685B69C-F997-4645-A47E-0A09F7D29CCEQ40843389-C6C6D3FE-7071-4C52-9E66-572237244717Q42704018-0EF990E2-011B-4D2B-B006-83D948D68819Q45911936-D7E9F785-1227-4032-BA74-46D5AD15BF59Q50856445-DF1D5120-AD20-4372-BC9B-BC8EC1F3B8B7Q51685341-96C88224-9F83-4B43-B542-C6FDE9FE236A
P2860
Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Development and evaluation of ...... hepatocarcinogens in the rat.
@en
Development and evaluation of ...... hepatocarcinogens in the rat.
@nl
type
label
Development and evaluation of ...... hepatocarcinogens in the rat.
@en
Development and evaluation of ...... hepatocarcinogens in the rat.
@nl
prefLabel
Development and evaluation of ...... hepatocarcinogens in the rat.
@en
Development and evaluation of ...... hepatocarcinogens in the rat.
@nl
P2093
P2860
P356
P1476
Development and evaluation of ...... hepatocarcinogens in the rat.
@en
P2093
Andrew Kincaid
Andrew Olaharski
David Jacobson-Kram
Eric Boitier
George Searfoss
Jiri Aubrecht
Jon Sherlock
P2860
P356
10.1093/TOXSCI/KFR202
P577
2011-08-02T00:00:00Z